Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1.

ABSTRACT:

Background

The identification of bioactive compounds from Chinese medicine plays a crucial role in the development of novel reagents against non-small lung cancer (NSCLC).

Methods

High throughput screening assay and analyses of cell growth, cell cycle, apoptosis, cDNA microarray, BrdU incorporation and gene expression were performed.

Results

Ailanthone (Aila) suppressed NSCLC cell growth and colony formation in vitro and inhibited NSCLC tumour growth in subcutaneously xenografted and orthotopic lung tumour models, leading to prolonged survival of tumour-bearing mice. Moreover, Aila induced cell cycle arrest in a dose-independent manner but did not induce apoptosis in all NSCLC cells. Furthermore, 1222 genes were differentially expressed upon Aila administration, which

SUBMITTER: Ni Z 

PROVIDER: S-EPMC5729430 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature